Fortress Biotech, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Common Stock (Tables)

Common Stock (Tables)

6 Months Ended

Jun. 30, 2014

Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]

Components of Stock-Based Compensation Expenses

The following table summarizes the stock-based compensation expense from stock option awards, restricted common stock awards, employee stock purchase programs and warrants for the three and six months ended June 30, 2014 and 2013:

	For the three months ended June 30,				For the six months ended June 30,
($ in thousands)	2014		2013		2014		2013
Employee awards	$	1,452	$	1,044	$	2,574	$	2,016
Non-employee awards		11		218		24		652
Non-employee warrants				21				138
Total stock-based compensation expense	$	1,463	$	1,283	$	2,598	$	2,806

Summary of Stock Option Activity

The following table summarizes stock option activity:

	Outstanding Options					Weighted
($ in thousands except per share amounts)		Number of Shares	Weighted Average Exercise Price		Total Weighted Average Intrinsic Value	Average Remaining Contractual Life (in years)
At December 31, 2013		3,117,777	$	4.31	$	8.36
Options granted
Options exercised		(323,412)		1.84
Options cancelled		(630,000)		4.28
At June 30, 2014		2,164,365	$	4.69	$	7.89
Options vested and expected to vest		2,164,365	$	4.69	$	7.89
Options vested and exercisable		1,587,699	$	4.42	$	7.62

Nonvested Restricted Stock Shares Activity

The following table summarizes restricted stock activity:

	Restricted Stock
	Number of Shares		Weighted Average Grant Date Fair Value
Unvested balance at December 31, 2013		3,958,692	$	1.93
Restricted stock granted		4,343,692		2.69
Restricted stock cancelled		(15,000)		2.69
Unvested balance at June 30, 2014		8,287,384	$	2.33

Summary of Warrant Activity

The following table summarizes warrant activity:

	Warrants
	Number of Shares		Weighted Average Grant Date Fair Value
Outstanding at December 31, 2013		711,894	$	6.63
Warrants cancelled due to expiration		(26,833)		6.15
Outstanding at June 30, 2014		685,061	$	6.65

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References + Details